🔥 TRENDING One dead as fire engulfs Lajpat Nagar... Aishwarya Rai Stuns in Cannes 2026 Gow... Air India’s Vista Platform Wins ‘Seaml... MAMA Awards 2026: Broadcast dates and... Five Teens Charged with Murder in Aust... Activist Archivists Revive Vintage Hom...
20 Nov 2026•
ગુજરાતી मराठी ਪੰਜਾਬੀ বাংলা
Sun Pharma Ordered to Shut Assam Eye‑Drop Plant Over Quality Lapses
📷 Image: Wikimedia Commons / Ministry of Health and Family Welfare
Business

Sun Pharma Ordered to Shut Assam Eye‑Drop Plant Over Quality Lapses

✍️ Business Today 🗓 31 Oct 2026, 11:33 AM 👁 267
Share: 💬 WhatsApp 📘 Facebook 𝕏 Post

The Drugs Controller General of India has directed Sun Pharma to shut its eye‑drop manufacturing unit in Assam following repeated quality violations. The decision follows a series of inspections that found the plant failing to meet GMP standards.

Sun Pharma has been directed by the Drugs Controller General of India to shut its eye‑drop manufacturing unit in Assam after a series of inspections revealed serious quality lapses. The order, issued on Monday, cites repeated violations of Good Manufacturing Practice (GMP) guidelines and failure to maintain sterility standards. The plant, which supplies eye‑drops to several markets, had previously been flagged for sub‑standard testing procedures and inadequate record keeping. Sun Pharma has stated that it will cooperate with authorities and will resume production once corrective measures are approved. The closure is expected to affect supply chains for certain eye‑drop brands until the company resolves the compliance issues.
📲Get App